Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Additional paid-in capital	Accumulated deficit	Accumulated other comprehensive income (loss)	Class A Common Stock	Class A Common Stock Common Stock
Beginning balance (in shares) at Dec. 31, 2024						28,016,545
Beginning balance at Dec. 31, 2024	$ 245,247	$ 1,596,889	$ (1,352,474)	$ 830		$ 2
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(3,355)		(3,355)
Common stock issued pursuant to stock option exercises (in shares)						38,168
Common stock issued pursuant to stock option exercises	982	982
Stock-based compensation expense	22,382	22,382
Vested restricted stock units converted to common stock (in shares)						560,935
Issuance of common stock pursuant to employee stock purchase plan (in shares)						22,674
Issuance of common stock pursuant to employee stock purchase plan	1,262	1,262
Issuance of common stock (in shares)						251,367
Issuance of common stock	25,568	25,568
Other comprehensive income (loss), net of tax	172			172
Ending balance (in shares) at Sep. 30, 2025						28,889,689
Ending balance at Sep. 30, 2025	292,258	1,647,083	(1,355,829)	1,002		$ 2
Beginning balance (in shares) at Jun. 30, 2025						28,708,058
Beginning balance at Jun. 30, 2025	277,133	1,624,513	(1,348,194)	812		$ 2
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(7,635)		(7,635)
Common stock issued pursuant to stock option exercises (in shares)						2,736
Common stock issued pursuant to stock option exercises	182	182
Stock-based compensation expense	10,586	10,586
Vested restricted stock units converted to common stock (in shares)						77,528
Issuance of common stock (in shares)						101,367
Issuance of common stock	11,802	11,802
Other comprehensive income (loss), net of tax	190			190
Ending balance (in shares) at Sep. 30, 2025						28,889,689
Ending balance at Sep. 30, 2025	$ 292,258	1,647,083	(1,355,829)	1,002		$ 2
Beginning balance (in shares) at Dec. 31, 2025	29,245,296					29,245,296
Beginning balance at Dec. 31, 2025	$ 308,182	1,680,738	(1,373,495)	936		$ 3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(93,383)		(93,383)
Common stock issued pursuant to stock option exercises (in shares)					2,314	2,314
Common stock issued pursuant to stock option exercises	58	58
Stock-based compensation expense	23,591	23,591
Vested restricted stock units converted to common stock (in shares)						579,592
Issuance of common stock pursuant to Securities Purchase Agreement (in shares)						81,967
Issuance of common stock pursuant to Securities Purchase Agreement and other	5,000	5,000
Issuance of common stock pursuant to employee stock purchase plan and other (in shares)						39,918
Issuance of common stock pursuant to employee stock purchase plan and other	1,812	1,812
Issuance of common stock (in shares)						5,390
Issuance of common stock	476	476
Other comprehensive income (loss), net of tax	$ (1,047)			(1,047)
Ending balance (in shares) at Sep. 30, 2026	29,954,477					29,954,477
Ending balance at Sep. 30, 2026	$ 244,689	1,711,675	(1,466,878)	(111)		$ 3
Beginning balance (in shares) at Jun. 30, 2026						29,803,164
Beginning balance at Jun. 30, 2026	244,221	1,698,427	(1,454,551)	342		$ 3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(12,327)		(12,327)
Common stock issued pursuant to stock option exercises	0
Stock-based compensation expense	8,253	8,253
Vested restricted stock units converted to common stock (in shares)						69,346
Issuance of common stock pursuant to Securities Purchase Agreement (in shares)						81,967
Issuance of common stock pursuant to Securities Purchase Agreement and other	4,995	4,995
Other comprehensive income (loss), net of tax	$ (453)			(453)
Ending balance (in shares) at Sep. 30, 2026	29,954,477					29,954,477
Ending balance at Sep. 30, 2026	$ 244,689	$ 1,711,675	$ (1,466,878)	$ (111)		$ 3